Come up with a name for your new list and we'll add to it:
MolecularMD raised a round of funding on May 20, 2013. Investors include
Ballast Point Ventures.
MolecularMD is a provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in Molecu…